CRDF Analyst Estimates: Price Targets, Revenue, Net Income, and EBIT Forecast - Cardiff Oncology Inc - Alpha Spread

First Time Loading...

Watchlist Manager

Watchlist

Price: 3.46 USD -1.7%

Updated:

Section:

Wall Street
Price Targets

Wall Street analysts forecast CRDF stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CRDF is 10.71 USD with a low forecast of 7.07 USD and a high forecast of 14.7 USD.

CRDF Lowest Forecast

Wall Street Target

CRDF Average Forecast

Wall Street Target

CRDF Highest Forecast

Wall Street Target

104% Upside

210% Upside

325% Upside

The latest public price target was made on Jun 5, 2022 by Joseph Catanzaro from Piper Sandler , who expects CRDF stock to rise by 102% over the next 12 months. You can read more about this price target by viewing the article on Pulse 2.0.

Analyst	Price Target	Date	Article
Joseph Catanzaro Piper Sandler	7 USD Upside 102%	1 year ago Jun 5, 2022	Cardiff Oncology (CRDF) Stock Price: $7 Target And Overweight Rating Pulse 2.0

Price Target	7 USD
Upside/Downside	102%

Avid Bioservices Inc

51% Upside

Avacta Group PLC

107% Upside

TOT BIOPHARM International Co Ltd

108% Upside

Niox Group PLC

10% Upside

Avid Bioservices Inc

51% Upside

Avacta Group PLC

107% Upside

TOT BIOPHARM International Co Ltd

108% Upside

Niox Group PLC

10% Upside

Ascletis Pharma Inc

117% Upside

Turnstone Biologics Corp

339% Upside

Beigene Ltd

38% Upside

Regeneron Pharmaceuticals Inc

12% Upside

Revenue
Forecast

For the last 8 years the compound annual growth rate for Cardiff Oncology Inc's revenue is 6%.

6%

N/A

15%

What are analyst estimates?

Operating Income
Forecast

N/A

N/A

-3%

What are analyst estimates?

Net Income
Forecast

N/A

N/A

-88%

What are analyst estimates?

See Also

Relative Valuation

Wall Street Estimates

Profitability Analysis

Solvency Analysis

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

According to Wall Street analysts, the average 1-year price target for CRDF is 10.71 USD with a low forecast of 7.07 USD and a high forecast of 14.7 USD.

Join more than 134,900+ value investors using Alpha Spread

Create a free account

or see our plans & pricing

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

What is Intrinsic Value? Help Center Contact Us

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.